- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2017-03-08 16:53:36
- Reporting Period:
- Filing Date:
- Accepted Time:
- 2017-03-08 16:53:36
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1433642||Hamilton Lane Inc||HLNE||Investment Advice (6282)||262482738|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1698040||Juan Delgado-Moreira||C/o Hamilton Lane Incorporated |
One Presidential Blvd., 4Th Floor
Bala Cynwyd PA 19004
Reported Non-Derivative Transactions
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Class A Common Stock||Acquisiton||2017-03-06||1,550,965||$0.00||1,550,965||No||4||J||Direct|
|Class A Common Stock||Acquisiton||2017-03-06||2,800||$16.00||1,553,765||No||4||P||Direct|
|Restricted Class A Common Stock||Acquisiton||2017-03-06||77,868||$0.00||1,628,833||No||4||J||Direct|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
Reported Derivative Transactions
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Class A Common Stock||Employee Stock Option (right to buy)||Acquisiton||2017-03-06||233,495||$0.00||233,495||$1.34|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- In the reorganization (the "Reorganization") of Hamilton Lane Advisors, L.L.C. ("HLA") in connection with the Issuer's initial public offering (the "IPO"), the reporting person exchanged membership interests of HLA owned prior to the IPO for Class A Common Stock of the Issuer.
- Purchase of shares in Issuer's directed share program in connection with its initial public offering.
- Represents the number of shares issued to the reporting person pursuant to an award of restricted stock under the Issuer's 2017 Equity Incentive Plan. The award was issued in substitution for existing awards of restricted interests in HLA that were issued annually in the years prior to the IPO, and the new award vests according to the same vesting schedule as the replaced awards: in four equal annual installments each March. Accordingly, one tranche will vest in 2017, one in 2018, one in 2019 and one in 2020.
- These options were granted under the Issuer's 2017 Equity Incentive Plan in substitution for outstanding options to purchase non-voting interests of HLA that were issued in 2007, prior to the IPO. The options being replaced were fully vested, and so the substitute award is fully vested.